Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (31 ops.)
Latest filing published 02 Oct 2026 for Oric Pharmaceuticals, Inc., €4,940. Read the official filing
Filing timeline
BuySaleRichard A. Heyman
Insider track record
Disclosed buys
0
Disclosed sells
31
Signal history
Richard A. Heyman: trading record in brief
Filings by Richard A. Heyman span 4 companies, the busiest being Enliven Therapeutics, Inc., Oric Pharmaceuticals, Inc. and PMV Pharmaceuticals, Inc. The record holds 37 filings, for trades running from 11 May 2021 to 1 October 2026.
The open-market record consists of 31 sales worth €940k, with no purchase. Outside the open market, there are 1 share grant and 4 option exercises. So far in 2026, the count stands at no purchases and 9 sales.
On 2 October 2026 came the latest disclosure, an open-market sale for €36k in Oric Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Richard A. Heyman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations37 total
3,500 shares@ US$1.600.0004% mcap1.1% of flowCommon StockSEC:0001584759-26-000017:0
3,500 shares@ US$12.91410.0032% mcap9.1% of flowCommon StockSEC:0001584759-26-000017:1
3,200 shares@ US$12.91410.0029% mcap8.3% of flowCommon StockSEC:0001584759-26-000017:2
3,500 shares@ US$1.600.0004% mcap1.4% of flowCommon StockSEC:0001584759-26-000015:0
7,000 shares@ US$12.020.0061% mcap20.7% of flowCommon StockSEC:0001584759-26-000015:1
6,100 shares@ US$12.020.0053% mcap18.0% of flowCommon StockSEC:0001584759-26-000015:2
300 shares@ US$12.000.0003% mcap0.9% of flowCommon StockSEC:0001584759-26-000012:0
1,230 shares@ US$26.17591.1% of flowCommon StockSEC:0001584759-26-000009:0
512 shares@ US$26.45920.5% of flowCommon StockSEC:0001584759-26-000007:0
3,500 shares@ US$12.004610.1% of flowCommon StockSEC:0001584759-26-000006:0
1,620 shares@ US$25.000.0009% mcap1.4% of flowCommon StockSEC:0001584759-26-000004:0
31,353 shares@ US$1.6012.0% of flowCommon StockSEC:0001584759-25-000004:0
817 shares@ US$30.0030.9% of flowCommon StockSEC:0001415889-24-025500:0
1,270 shares@ US$27.67191.3% of flowCommon StockSEC:0001415889-24-025381:0
2,825 shares@ US$27.50572.8% of flowCommon StockSEC:0001415889-24-024899:0
518 shares@ US$27.53730.5% of flowCommon StockSEC:0001415889-24-024668:0
1,270 shares@ US$22.4081.0% of flowCommon StockSEC:0001415889-24-023610:0
650 shares@ US$22.81620.5% of flowCommon StockSEC:0001415889-24-021644:0
1,702 shares@ US$27.50591.7% of flowCommon StockSEC:0001415889-24-020685:0
1,270 shares@ US$24.80061.2% of flowCommon StockSEC:0001415889-24-019731:0
1,270 shares@ US$21.47871.0% of flowCommon StockSEC:0001415889-24-017715:0
1,270 shares@ US$23.73991.1% of flowCommon StockSEC:0001415889-24-013833:0
5,045 shares@ US$25.03064.7% of flowCommon StockSEC:0001415889-24-010825:0
1,270 shares@ US$14.50290.7% of flowCommon StockSEC:0001415889-24-008883:0
367,446 shares@ US$62.50100.0% of flowCommon StockSEC:0001415889-24-005525:0
25 of 37 declarations
